|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
透明质酸肿瘤靶向给药系统的研究进展
, PP. 1376-1382
Keywords: 透明质酸,药物载体,肿瘤靶向
Abstract:
透明质酸(hyaluronicacid,ha)作为抗癌药物传递载体应用于肿瘤治疗领域,已成为肿瘤靶向给药系统研究的热点。ha本身具有识别肿瘤细胞表面过度表达的特定受体的能力,可以将抗癌药物靶向传递到肿瘤细胞内,从而更好地杀死肿瘤细胞。本文主要介绍了ha的基本特性和肿瘤靶向的生理学基础,同时,重点综述了近年来基于不同形式的ha肿瘤靶向给药系统的研究进展。
| [1] | xuk,leef,gaosj,etal.injectablehyaluronicacid-tyraminehydrogelsincorporatinginterferon-α2aforlivercancertherapy[j].jcontrolrelease,2013,166:203-210.
|
| [2] | yaoj,zhoujp,pingqn,etal.effectofhyaluronicacidchitosan-basedmicroemulsiononthepermeabilityofbloodbrainbarrierinmice[j].actapharmsin(药学学报),2006,41:801-804.
|
| [3] | prestwichgd.hyaluronicacid-basedclinicalbiomaterialsderivedforcellandmoleculedeliveryinregenerativemedicine[j].jcontrolrelease,2011,155:193-199.
|
| [4] | misras,heldinp,hascallvc,etal.hyaluronan-cd44interactionsaspotentialtargetsforcancertherapy[j].febsj,2011,278:1429-1443.
|
| [5] | choiky,jeonej,yoonhy,etal.theranosticnanoparticlesbasedonpegylatedhyaluronicacidforthediagnosis,therapyandmonitoringofcoloncancer[j].biomaterials,2012,33:6186-6193.
|
| [6] | weig,dingpt,cuiyy,etal.effectofsolutionviscosityonpolymerprecornealresidencetimeevaluatedbyinvitromethod[j].actapharmsin(药学学报),2002,37:469-472.
|
| [7] | huangys,panym,xuej.researchonthefunctionandapplicationofhyaluronicacidwithdifferentmolecularweights[j].chinjdialartiforgan(透析与人工器官),2010,21:22-25.
|
| [8] | pravatal,braudc,bousttam,etal.newamphiphiliclacticacidoligomer-hyaluronanconjugates:synthesisandphysicochemicalcharacterization[j].biomacromolecules,2008,9:340-348.
|
| [9] | plattvm,szokafcjr.anticancertherapeutics:targetingmacromoleculesandnanocarrierstohyaluronanorcd44,ahyaluronanreceptor[j].molpharm,2008,5:474-486.
|
| [10] | bourguignonly,peyrollierk,gilade.hyaluronan-cd44interactionwithneuralwiskott-aldrichsyndromeprotein(n-wasp)promotesactinpolymerizationanderbb2activationleadingtobeta-cateninnucleartranslocation,transcriptionalup-regulation,andcellmigrationinovariantumorcells[j].jbiolchem,2007,282:1265-1280.
|
| [11] | choiky,saravanakumarg,parkjh,etal.hyaluronicacid-basednanocarriersforintracellulartargeting:interfacialinteractionswithproteinsincancer[j].colloidssurfbbiointerfaces,2012,99:82-94.
|
| [12] | ouastis,kinghampj,terenghig,etal.thecd44/integrinsinterplayandthesignificanceofreceptorbindingandre-presentationintheuptakeofrgd-functionalizedhyaluronicacid[j].biomaterials,2012,33:1120-1134.
|
| [13] | haradah,takahashim.cd44-dependentintracellularandextracellularcatabolismofhyaluronicacidbyhyaluronidase-1and-2[j].jbiolchem,2007,282:5597-5607.
|
| [14] | lisignolig,grassif,zinin,etal.anti-fas-inducedapoptosisinchondrocytesreducedbyhyaluronan:evidenceforcd44andcd54(intercellularadhesionmolecule1)involvement[j].arthritisrheum,2001,44:1800-1807.
|
| [15] | wardja,huangl,guoh,etal.perturbationofhyaluronaninteractionsinhibitsmalignantpropertiesofgliomacells[j].amjpathol,2003,162:1403-1409.
|
| [16] | galerce,sanod,ghoshsc,etal.hyaluronicacid-paclitaxelconjugateinhibitsgrowthofhumansquamouscellcarcinomasoftheheadandneckviaahyaluronicacid-mediatedmechanism[j].oraloncol,2011,47:1039-1047.
|
| [17] | cais,xiey,bagbytr,etal.intralymphaticchemotherapyusingahyaluronan-cisplatinconjugate[j].jsurgres,2008,147:247-252.
|
| [18] | cais,xiey,daviesnm,etal.pharmacokineticsanddispositionofalocalizedlymphaticpolymerichyaluronanconjugateofcisplatininrodents[j].jpharmsci,2010,99:2664-2671.
|
| [19] | speranzaa,pellizzaroc,coradinid.hyaluronicacidbutyricestersincancertherapy[j].anticancerdrugs,2005,16:373-379.
|
| [20] | xind,wangy,xiangj.theuseofaminoacidlinkersintheconjugationofpaclitaxelwithhyaluronicacidasdrugdeliverysystem:synthesis,self-assembledproperty,drugrelease,andinvitroefficiency[j].pharmres,2010,27:380-389.
|
| [21] | jial,qiaomx,huhy,etal.thecharacterisiticsoftemperature/phsensitiveblockcopolymermicellesinvitro[j].actapharmsin(药学学报),2011,46:839-844.
|
| [22] | chohj,yoonhy,kooh,etal.self-assemblednanoparticlesbasedonhyaluronicacid-ceramide(ha-ce)andpluronic®fortumor-targeteddeliveryofdocetaxel[j].biomaterials,2011,32:7181-7190.
|
| [23] | jeongyi,kimdoh,chungcw,etal.self-assemblednanoparticlesofhyaluronicacid/poly(dl-lactide-co-glycolide)blockcopolymer[j].colloidssurfbbiointerfaces,2012,90:28-35.
|
| [24] | choiky,chungh,minkh,etal.self-assembledhyaluronicacidnanoparticlesforactivetumortargeting[j].biomaterials,2010,31:106-114.
|
| [25] | choiky,chungh,minkh,etal.self-assembledhyaluronicacidnanoparticlesasapotentialdrugcarrierforcancertherapy:synthesis,characterization,andinvivobiodistribution[j].jmaterchem,2009,19:4102-4107.
|
| [26] | choiky,minkh,yoonhy,etal.pegylationofhyaluronicacidnanoparticlesimprovestumortargetabilityinvivo[j].biomaterials,2011,32:1880-1889.
|
| [27] | peerd,margalitr.tumor-targetedhyaluronannanoliposomesincreasetheantitumoractivityofliposomaldoxorubicininsyngeneicandhumanxenograftmousetumormodels[j].neoplasia,2004,6:343-353.
|
| [28] | richertl,boulmedaisf,lavallep,etal.improvementofstabilityandcelladhesionpropertiesofpolyelectrolytemultilayerfilmsbychemicalcross-linking[j].biomacromolecules,2004,5:284-294.
|
| [29] | trosdeilarduyac,suny,duzgunesn.genedeliverybylipoplexesandpolyplexes[j].eurjpharmsci,2010,40:159-170.
|
| [30] | yaoj,fany,dur,etal.amphoterichyaluronicacidderivativefortargetinggenedelivery[j].biomaterials,2010,31:9357-9365.
|
| [31] | fany,yaoj,dur,etal.ternarycomplexeswithcore-shellbilayerfordoubleleveltargetedgenedelivery:invitroandinvivoevaluation[j].pharmres,2013,30:1215-1227.
|
| [32] | choiky,yoonhy,kimjh,etal.smartnanocarrierbasedonpegylatedhyaluronicacidforcancertherapy[j].acsnano,2011,5:8591-8599.
|
| [33] | oerthers,maurinac,payane.highinteractionalginate-hyaluronateassociationsbyhyaluronatedeacetylationforthepreparationofefficientbiomaterials[j].biopolymers,2000,54:273-281.
|
| [34] | lij,huom,wangj,etal.redox-sensitivemicellesself-assembledfromamphiphilichyaluronicaciddeoxycholicacidconjugatesfortargetedintracellulardeliveryofpaclitaxel[j].biomaterials,2012,33:2310-2320.
|
| [35] | gansaugef,gansauges,zobywalskia,etal.differentialexpressionofcd44splicevariantsinhumanpancreaticadenocarcinomaandinnormalpancreas[j].cancerres,1995,55:5499-5503.
|
| [36] | destefanoi,battagliaa,zannonigf,etal.hyaluronicacid-paclitaxel:effectsofintraperitonealadministrationagainstcd44(+)humanovariancancerxenografts[j].cancerchemotherpharmacol,2011,68:107-116.
|
| [37] | chohj,yoonis,yoonhy,etal.polyethyleneglycol-conjugatedhyaluronicacid-ceramideself-assemblednanoparticlesfortargeteddeliveryofdoxorubicin[j].biomaterials,2012,33:1190-1200.
|
| [38] | eliazre,szokafcjr.liposome-encapsulateddoxorubicintargetedtocd44:astrategytokillcd44-overexpressingtumorcells[j].cancerres,2001,61:2592-2601.
|
| [39] | hyungw,koh,parkj,etal.novelhyaluronicacid(ha)coateddrugcarriers(hcdcs)forhumanbreastcancertreatment[j].biotechnolbioeng,2008,99:442-454.
|
| [40] | rivkini,cohenk,kofflerj,etal.paclitaxelclusterscoatedwithhyaluronanasselectivetumor-targetednanovectors[j].biomaterials,2010,31:7106-7114.
|
| [41] | el-dakdoukimh,zhudc,el-boubbouk,etal.developmentofmultifunctionalhyaluronan-coatednanoparticlesforimaginganddrugdeliverytocancercells[j].biomacromolecules,2012,13:1144-1151.
|
| [42] | schneidera,picartc,sengerb,etal.layer-by-layerfilmsfromhyaluronanandamine-modifiedhyaluronan[j].langmuir,2007,23:2655-2662.
|
| [43] | huangw,lüm,gaozg,etal.smallinterferingrnadeliverymediatedbympeg-pcl-g-peipolymernanoparticles[j].actapharmsin(药学学报),2011,46:344-349.
|
| [44] | wangxl,wangqq,songhf.advanceinthestudyoftargetingdeliverysystemforsirnamediatedbyaptamers[j].actapharmsin(药学学报),2012,47:850-855.
|
| [45] | sheny,wangb,luy,etal.anoveltumor-targeteddeliverysystemwithhydrophobizedhyaluronicacid-spermineconjugates(hhscs)forefficientreceptor-mediatedsirnadelivery[j].intjpharm,2011,414:233-243.
|
| [46] | parkk,leemy,kimks,etal.targetspecifictumortreatmentbyvegfsirnacomplexedwithreduciblepolyethyleneimine-hyaluronicacidconjugate[j].biomaterials,2010,31:5258-5265.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
